Literature DB >> 18573594

Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate.

Daniel Ezekwudo1, Rangaiah Shashidharamurthy, Dilip Devineni, Erica Bozeman, Ravi Palaniappan, Periasamy Selvaraj.   

Abstract

Hormone refractory human prostate cancer cell lines are known to be radioresistant, a feature attributed to their ability to induce anti-apoptotic proteins of the Bcl-2 family when exposed to radiation. We investigated whether pro-apoptotic compounds such as methyl jasmonate, a plant stress hormone, can counteract the radiation-induced anti-apoptotic mechanism in a human prostate cancer cell line PC-3. Significant (p<0.05) increase in cytotoxicity was observed in the combined treatment groups compared to single treatments with methyl jasmonate or gamma-radiation. Treatment of irradiated PC-3 cells with methyl jasmonate resulted in suppression of anti-apoptotic Bcl-2 protein and elevation of caspase-3 activity. Our results showed increased apoptosis in the combined treatment group as compared to the irradiated group or the untreated control. In summary, methyl jasmonate suppressed the radiation-induced Bcl-2 expression and enhanced the radiation sensitivity of human prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573594     DOI: 10.1016/j.canlet.2008.05.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

1.  Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity.

Authors:  Ashley E Ross; Ashkan Emadi; Luigi Marchionni; Paula J Hurley; Brian W Simons; Edward M Schaeffer; Milena Vuica-Ross
Journal:  BJU Int       Date:  2010-12-22       Impact factor: 5.588

2.  NES1/KLK10 and hNIS gene therapy enhanced iodine-131 internal radiation in PC3 proliferation inhibition.

Authors:  Jiajia Hu; Wenbin Shen; Qian Qu; Xiaochun Fei; Ying Miao; Xinyun Huang; Jiajun Liu; Yingli Wu; Biao Li
Journal:  Front Med       Date:  2019-05-22       Impact factor: 4.592

Review 3.  Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication.

Authors:  Minjong Lee; Jung-Hwan Yoon
Journal:  World J Biol Chem       Date:  2015-08-26

4.  Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin.

Authors:  Laxmi Yeruva; Casey Hall; John Abiodun Elegbede; Stephen W Carper
Journal:  Anticancer Drugs       Date:  2010-01       Impact factor: 2.248

5.  Melittin radiosensitizes esophageal squamous cell carcinoma with induction of apoptosis in vitro and in vivo.

Authors:  Hongcheng Zhu; Xi Yang; Jia Liu; Yangyang Ge; Qin Qin; Jing Lu; Liangliang Zhan; Zheming Liu; Hao Zhang; Xiaochen Chen; Chi Zhang; Liping Xu; Hongyan Cheng; Xinchen Sun
Journal:  Tumour Biol       Date:  2014-05-29

6.  Liriodenine enhances radiosensitivity in esophageal cancer ECA-109 cells by inducing apoptosis and G2/M arrest.

Authors:  Gang Wu; Guangzong Chen; Jialiang Zhou; Hongcheng Zhu; Jianjun Chu; Fuzheng Zhang
Journal:  Oncol Lett       Date:  2018-08-02       Impact factor: 2.967

7.  Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation.

Authors:  Elad Milrot; Anna Jackman; Eliezer Flescher; Pinhas Gonen; Itzhak Kelson; Yona Keisari; Levana Sherman
Journal:  Invest New Drugs       Date:  2012-09-06       Impact factor: 3.850

Review 8.  Jasmonate Compounds and Their Derivatives in the Regulation of the Neoplastic Processes.

Authors:  Iwona Jarocka-Karpowicz; Agnieszka Markowska
Journal:  Molecules       Date:  2021-05-13       Impact factor: 4.411

9.  Algae extracts and methyl jasmonate anti-cancer activities in prostate cancer: choreographers of 'the dance macabre'.

Authors:  Ammad Ahmad Farooqi; Ghazala Butt; Zubia Razzaq
Journal:  Cancer Cell Int       Date:  2012-11-26       Impact factor: 5.722

10.  The synergistic effects of traditional Chinese herbs and radiotherapy for cancer treatment.

Authors:  Lili Jia; Shumei Ma; Xue Hou; Xin Wang; Abu Baker Layth Qased; Xuefei Sun; Nan Liang; Huicheng Li; Heqing Yi; Dejuan Kong; Xiaodong Liu; Feiyue Fan
Journal:  Oncol Lett       Date:  2013-03-12       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.